Home › Pulmonary Arterial Hypertension › Maryland
Pulmonary Arterial Hypertension clinical trials in Maryland
5 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Maryland.
Cities in Maryland
Spironolactone for Pulmonary Arterial Hypertension
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Oct 2, 2026 · NCT01712620Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 23, 2026 · NCT07613099Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
- The Johns Hopkins Hospital, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT06992440Pulmonary Hypertension Association Registry
- University of MD Medical Group, PA, Baltimore
- Johns Hopkins University, Baltimore
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Johns Hopkins Children's Center, Baltimore
RecruitingObservational study
1 Day – 21 Years · All sexes · Updated Mar 13, 2025 · NCT02249923From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.